Home/ Crypto News/ Xenon Pharmaceuticals (XENE) Plunges 25% on Psychiatric Trial Halt: Is Now the Time to Buy?

blockonomi 12 hours ago

Xenon Pharmaceuticals (XENE) Plunges 25% on Psychiatric Trial Halt: Is Now the Time to Buy?

Stocks

Xenon Pharmaceuticals (XENE) stock plummeted 25% after pausing psychiatric trials due to adverse events, though it filed for epilepsy drug approval.

The post Xenon Pharmaceuticals (XENE) Plunges 25% on Psychiatric Trial Halt: Is Now the Time to Buy? appeared first on Blockonomi.

Source: Source: Blockonomi